NCT04477213

Brief Summary

The investigators propose to conduct a retrospective study to define and quantify the variable occupational and non-occupational risk among various HCWs who got COVID-19 . The investigators aim to determine the rates of acquisition of COVID-19, in the context of level of exposure , adequacy of PPE use and other infection control measuresrecommended for COVID-19 and also to define the risk of secondary disease transmission to other household members of HCWs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
286

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 17, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 20, 2020

Completed
1.1 years until next milestone

Study Start

First participant enrolled

September 11, 2021

Completed
19 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2021

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 2, 2021

Completed
Last Updated

October 11, 2021

Status Verified

September 1, 2021

Enrollment Period

19 days

First QC Date

July 17, 2020

Last Update Submit

October 4, 2021

Conditions

Keywords

COVID-19Healthcare Workersoccupational risk of COVID-19

Outcome Measures

Primary Outcomes (1)

  • Rate of COVID-19 in healthcare workers (HCWs)

    Positive HCW divided by total exposed HCWs in that category X 100 Rate will be calculated in 4 different categories. 1. Front line HCWs (doctors, nurses, respiratory therapist, physiotherapist, dialysis technician, patient assistant etc) 2. Front line support staffs (Customer care, pharmacist, billing assistance, ambulance driver etc.), 3. Clinical support staffs- (dietician, food service worker, laundry worker, housekeeping staffs, health record staffs- infection control team etc.) 4. Non-clinical support staffs- (Administrative support staff.)

    6 months

Secondary Outcomes (1)

  • clinical severity of infection in HCWs

    Within 28 days of illness.

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All Healthcare workers working actively in the included hospitals or clinics and are confirmed positive with COVID-19

You may qualify if:

  • All staffs that are currently working in included hospitals and clinic in 1.2.1.1 Laboratory confirmed positive case- A positive case is where COVID-19 virus is detected through real time polymerase chain reaction (RT PCR) either through oropharyngeal or nasopharyngeal swab which were conducted on HCWs based on national guidelines of UAE and are based on either symptoms, or as part of contact tracing or history of recent international travel.
  • Laboratory confirmed positive case with history of occupational exposure- through contact tracing after an exposure to a known COVID -19 patient in a healthcare setting.
  • Laboratory confirmed positive case with no history of occupational exposure- non-occupational exposures include situations where there was no probable workplace exposure for the healthcare worker, and a community source for the infection through household contact, travel, gathering in public places or visiting to affected area as most likely source of exposure is identified.

You may not qualify if:

  • Staff who refused to participate or withdraw there consent during the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NMC Specialty Hospital, Al Nahda

Dubai, United Arab Emirates

Location

Related Publications (2)

  • Nguyen LH, Drew DA, Joshi AD, Guo CG, Ma W, Mehta RS, Sikavi DR, Lo CH, Kwon S, Song M, Mucci LA, Stampfer MJ, Willett WC, Eliassen AH, Hart JE, Chavarro JE, Rich-Edwards JW, Davies R, Capdevila J, Lee KA, Lochlainn MN, Varsavsky T, Graham MS, Sudre CH, Cardoso MJ, Wolf J, Ourselin S, Steves CJ, Spector TD, Chan AT. Risk of COVID-19 among frontline healthcare workers and the general community: a prospective cohort study. medRxiv [Preprint]. 2020 May 25:2020.04.29.20084111. doi: 10.1101/2020.04.29.20084111.

  • Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648. No abstract available.

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Helen King, RN DMS MBA

    Senior Vice President: Nursing & Quality Corporate Quality & Nursing

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Specialist Critical Care Medicine

Study Record Dates

First Submitted

July 17, 2020

First Posted

July 20, 2020

Study Start

September 11, 2021

Primary Completion

September 30, 2021

Study Completion

October 2, 2021

Last Updated

October 11, 2021

Record last verified: 2021-09

Locations